Further information for existing investors.

  • Eurovestech PLC floated on AIM in March 2000. The company raised a £9.9m fund at 5p per share inclusive of Richard Bernstein’s personal investment of £2m on the same terms as institutional shareholders. Between 2003 and 2008, the company raised a further £11.7 million. Our cautious approach has steered us successfully through the pitfalls of an over-inflated market.

    The Company returned £10m to shareholders via the Return of Cash scheme augmented in March 2010. Following the successful completion of the Toluna scheme of arrangement in April 2011, the Company received £25m proceeds and returned £13m of these proceeds to shareholders, bringing total returns to shareholders of £23m, greater than the total monies raised by the Company.

    In September 2012, and following a partial disposal of KSS Fuels, the Company cancelled its admission to AIM and returned a further £4.4m to shareholders, bringing total cash returned to shareholders of 7.5p per share.

  • Investment strategy

    The Directors are responsible for identifying new investment opportunities for the Company that fall within the investment criteria set out above. Following the identification of a potential new investment opportunity, the Directors will be responsible for carrying out and overseeing all due diligence into the proposition and for negotiating the terms of investment on behalf of the Company.

    Key criteria for all investments include management expertise and vision, identifiable revenue and profit streams and strategic alliance opportunities. The Company has acquired a portfolio of investments spread across the four areas outlined above to reduce the specific risk to any one investment. The Company is prepared to provide seed capital, pre-float finance and mezzanine finance to companies and also provides further finance to companies to assist them to achieve their potential. The Company can also invest surplus cash resources in quoted investments.


    There are no investing restrictions in place but the board endeavours to prevent any single investment in any one company representing more than 20% of the gross asset value of the Company at the time of investment. There is no guarantee that this will be the case after any investment is made, particularly where it is believed that an investment is particularly attractive.

    It is possible that the Company may offer its own shares in exchange for shares in investee companies in addition to a cash investment in such companies.

    Remuneration Committee

    The Remuneration Committee meets at least twice each year. The committee comprises solely independent non-executive directors Richard Grogan (Chairman) and Quentin Solt.

    The committee sets the remuneration policy for the Chairman, the non-executive and executive directors. In consultation with the executive directors and professional advisers the Remuneration Committee agrees their service contracts, salaries, other benefits – including bonuses and participation in the company’s long-term incentive plans – and other terms and conditions of employment.

    It also agrees terms for their cessation of employment and their appointments as non-executive directors of investee companies and other organisations. It approves changes in the company’s long term incentive plans, recommends to the Board those plans which require shareholder approval and oversees their operation.

    Nomination Committee

    The Nomination Committee meets as necessary and is responsible for considering and recommending to the board persons who are appropriate for appointment as Executive and Non-Executive Directors. The committee receives proposals of suitable candidates either from existing board members or an external search firm for the appointment of new directors to the board. The Nomination Committee considers candidates by undertaking a formal, rigorous and transparent interview procedure. The committee gives careful consideration to ensure proposed appointees have enough time available to devote to the role and that the balance of skills, knowledge and experience on the board is maintained. When The committee has found a suitable candidate, the Chairman of The committee will make a proposal to the whole board, which has retained responsibility for all such appointments. The Chairman of The committee reports the outcome of its meetings to the board.

    Audit Committee

    The role of the Audit Committee is to monitor the financial reporting process, the integrity of the Group’s annual financial statements and the statutory audit of the consolidated accounts. It is also responsible for reviewing the Group’s internal financial control and risk management systems and the Company’s relationship with the external auditors.

    The committee meets with the auditors in advance of the year end audit to ascertain the appropriate audit approach and immediately prior to the publication of the Company’s audited final results statement. The committee invites senior officers of the Company to attend as appropriate.

  • The company “Eurovestech Plc” was founded in 2000 and incorporated in the United Kingdom. The main activities of the company are in the United Kingdom. Companies in which Eurovestech holds an equity interest operate in Europe, Asia and the United States.

    Shareholding Information

    There are currently 346,822,727 shares in issue.

    The Company’s significant shareholders are:

    Shareholding %
    Amvescap Plc 102,850,819 30.5
    Henderson Global 65,148,810 19.3
    Damille Investments II Limited 20,507,260 6.1
    Deutsche Bank AG 16,042,740 4.7
    Richard Bernstein 4,900,000 1.5
  • Shareholder Liquidity

    As of 6th June 2017, the shares of Eurovestech Plc were admitted to trading on Asset Match.

    Asset Match provides an electronic share trading platform to allow shareholders to buy and sell shares in unquoted companies through auctions held on a periodic auction basis. The first auction for Eurovestech will close on Wednesday 28th June 2017. Asset Match is Authorised and Regulated by the Financial Conduct Authority

    Investors interested in trading Eurovestech shares can register at where details of the service together with information on historical and current auctions can be found.

    For any further information please visit the Asset Match website or contact them directly.

    Asset Match’s contact details are:

    1 Bow Lane
    EC4M 9EE

    T: +44 (0)207 248 2788


  • In March 2000, Eurovestech made a commitment in its prospectus to issue 4,000,000 ordinary shares to a selection of charities within two years. To date, Eurovestech has issued 12,000,000 shares to a total of 107 separate charitable organisations.

    Eurovestech is pleased to note that together with the 4,600,000 shares donated to charities from Richard Bernstein’s personal holding, the stock market value of shares in Eurovestech gifted to worthy causes now exceeds £2.7 million.

    Richard Bernstein, Chief Executive of Eurovestech commented: “We are proud that so many great causes have been able to benefit from Eurovestech’s progress. We believe that this is an extremely simple and effective method of corporate share giving”.

    ‘Share and Share Alike Limited’ has been set up to assist and encourage other companies to follow suit to support charities in this way: Share & Share Alike.

    ‘WINNER of two Business Charity Awards 2010; Business Charity ChampionOutstanding Individual.’ Read more.

    Richard Bernstein paid the nominal value of the ordinary shares to facilitate the issue of shares to the charitable beneficiaries below:

    ABF (Army Benevolent Fund) The Soldiers’ Charity

    Alabare Christian Support

    Alzheimer’s Society

    Anthony Nolan Trust

    Battersea Dogs and Cats Home

    Borneo Orangutan Survival Organization UK

    Breast Cancer Charity

    British Agencies for Adoption and Fostering

    Cancer Research

    Care for Casualties

    Children’s Wish Foundation

    Chris Westwood Charity for Children with Physical Disabilities

    CIDA Foundation UK

    CLIC – Cancer and Leukaemia in Childhood

    Complimentary Cancer Care Trust

    Crossroads Association

    Diabetes UK

    Douglas House – The Oxford Respices for Children and Young People

    Dreams Come True

    Fondation Ensemble Switzerland

    Foundation for the United Nations Global Compact

    Fredericks Foundation

    Friends of Humanity, Switzerland

    Friends of Schneider Childrens Hospital

    Friends of Yad Sarah

    Great Ormond Street Hospital Children’s Charity

    Greater London Fund for the Blind

    Hadassah UK

    Hearing Dogs for Deaf People

    Help a London Child Appeal Fund

    Hermann-Gmeiner-Fonds Deutschland

    Imperial College Healthcare Charity

    Imperial College London

    International Childcare Trust

    International Myeloma Foundation

    International Paralympic Equestrian Committee

    Kent Multiple Sclerosis Therapy Centre


    Leukaemia Research Fund

    Listening Ear Merseyside

    Macmillan Cancer Support

    MAD Charity Ball (Care for Casualties/Help for Heroes)

    Management Accounting for Non Governmental Organisations Ltd (Mango)

    Marie Curie Cancer Care


    Metropolitan Sports and Social Club for the Visually Impaired


    Missing People

    Motor Neurone Disease Association

    Narconon London Ltd

    Nordoff Robbins Music Therapy

    Norwood Ravenswood Foundation

    One to One Children’s Fund

    Open Adaptive Rowing (OAR)

    Pilot Light Ltd

    Prostate Cancer Charity

    Riding for the Disabled Association



    Sight Savers International

    St Luke’s Hospice

    Teens Unite Fighting Cancer

    The Alumni of the London School of Economics and Political Science

    The American Red Cross

    The Association for International Cancer Research

    The Barrestown Gang Camp Fund for Seriously Ill Children

    The Bishop Simeon CR

    The British Friends of Soroka Medical Centre

    The British Heart Foundation

    The Caron Keating Foundation

    The Children’s Trust

    The City of London School Bursary Trust

    The Disabled Living Foundation

    The Evening Standard Dispossessed Fund

    The Good Rock Foundation

    The Guy’s and St Thomas’ Charitable Foundation

    The Haven House Children’s Hospice

    The Hospice of St Mary of Furness

    The Hospice of St. Francis (Berkhamsted)

    The Jo Weinberg Flute Award

    The Life Neurological Research Trust

    The London Youth Trust

    The Marfan Trust

    The Orpheus Centre

    The Richard House Children’s Hospice

    The Roy Castle Lung Cancer Foundation

    The Royal Opera House Foundation

    The Samara Orphanage

    The Samaritans

    The Shooting Star Children’s Hospice

    The Trussell Trust

    The UK Thailand Children’s Fund

    The WellChild Trust

    The Young Musicians Fund


    Tracks Autism

    Trinity Hospice

    Trustees of the Drugs Prevention Education and Awareness Project

    UK Sands

    United Nations Foundation for Global Impact

    University College London Hospitals Charity

    University of North London

    Vaccine Research Trust

    Variety Club of Great Britain

    Will Craddock Leukaemia Research Fund

    Willow Foundation

    Yechi Am Yisrael

    Yorkshire Cancer Research

Financial Reports